Redeye: Invisio - Record order intake support positive outlook
Redeye updates on Invisio post Q2-results which came in lower-than-expected owing to soft deliveries during the quarter. However, the order intake reached new record levels and the outlook remains strong. We make limited changes to our estimates and valuation range.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/